Busulfan and fludarabine is a safe and effective conditioning regimen for allogenic sibling bone marrow transplantation in adults with acute myeloid leukemia

被引：0
|
作者：
Fagot, T. [1 ]
Konopacki, J. [1 ]
Malfuson, J. [1 ]
Janus, G. [1 ]
Souleau, B. [1 ]
De Revel, T. [1 ]
机构：
[1] Hop Percy, Clamart, France
来源：
EXPERIMENTAL HEMATOLOGY | 2007年 / 35卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [31] Successful pregnancy following busulfan and cyclophosphamide conditioning and allogeneic bone marrow transplantation for chronic myeloid leukemia
    Matias, Kleber
    Matias, Carolina
    Teixeira, Heberton
    Freire, Ana Dulce
    Azevedo, Alta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (08) : 944 - 945
  • [32] Fludarabine-melphalan reduced-intensity conditioning matched sibling bone marrow stem cell transplantation is an effective treatment for myeloid disorders
    Malladi, R
    Peniket, A
    Collins, G
    Littlewood, T
    BONE MARROW TRANSPLANTATION, 2004, 33 : S116 - S116
  • [33] Fludarabine and Targeted Busulfan Is Safe and Effective Conditioning Before Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in First Remission
    Kunter, Ghada M.
    Perkins, Janelle
    Perez, Lia
    Pidala, Joseph
    Field, Teresa
    Tomblyn, Marcie
    Fernandez, Hugo F.
    Anasetti, Claudio
    BLOOD, 2011, 118 (21) : 407 - 407
  • [34] BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA
    ODONNELL, MR
    LONG, GD
    PARKER, PM
    NILAND, J
    NADEMANEE, A
    AMYLON, M
    CHAO, N
    NEGRIN, RS
    SCHMIDT, GM
    SLOVAK, ML
    SMITH, EP
    SNYDER, DS
    STEIN, AS
    TRAWEEK, T
    BLUME, KG
    FORMAN, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) : 2973 - 2979
  • [35] Melphalan and total-body irradiation as a conditioning regimen for autologous bone marrow transplantation in acute myeloid leukemia.
    Treleaven, J
    Powles, R
    Singhal, S
    Horton, C
    Tait, D
    Meller, S
    Pinkerton, CR
    Mehta, J
    BLOOD, 1995, 86 (10) : 3861 - 3861
  • [36] Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation
    Onishi, Yasushi
    Mori, Shin-ichiro
    Kusumoto, Shigeru
    Sugimoto, Kyoko
    Akahane, Daigo
    Morita-Hoshi, Yuriko
    Kim, Sung-Won
    Fukuda, Takahiro
    Heike, Yuji
    Tanosaki, Ryuji
    Tobinai, Kensei
    Takaue, Yoichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (03) : 256 - 263
  • [37] IV BUSULFAN AND FLUDARABINE (BUXFLU) AS TRANSPLANT CONDITIONING REGIMEN IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS: ANALYSIS OF A SINGLE CENTRE EXPERIENCE
    Rodriguez Macias, G.
    Munoz, C.
    Serrano, D.
    Gayoso, J.
    Balsalobre, P.
    Buno, I.
    Encinas, C.
    Gomez-Pineda, A.
    Diez-Martin, J. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 469 - 469
  • [38] Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
    Yasushi Onishi
    Shin-ichiro Mori
    Shigeru Kusumoto
    Kyoko Sugimoto
    Daigo Akahane
    Yuriko Morita-Hoshi
    Sung-Won Kim
    Takahiro Fukuda
    Yuji Heike
    Ryuji Tanosaki
    Kensei Tobinai
    Yoichi Takaue
    International Journal of Hematology, 2007, 85 : 256 - 263
  • [39] BUSULFAN AND CYCLOPHOSPHAMIDE (BU-CY) AS CONDITIONING REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    MELONI, G
    PORCELLINI, A
    CAROTENUTO, M
    DEFABRITIIS, P
    MANNA, A
    MANDELLI, F
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 561 - 561
  • [40] Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation
    Truscott, Laurel
    Pariury, Holly
    Hanmod, Santosh
    Davini, Monica
    de la Maza, Michelina
    Sapp, Lauren N.
    Staples, Kyleigh
    Proytcheva, Maria
    Katsanis, Emmanuel
    PEDIATRIC BLOOD & CANCER, 2023, 70 (02)
12345